Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04229966
Other study ID # PORTALS-AEDH
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 2, 2020
Est. completion date December 31, 2023

Study information

Verified date October 2021
Source RenJi Hospital
Contact Junfeng Feng, MD
Phone +8613611860825
Email fengjfmail@163.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This is a multicenter, prospective, and observational real-world study aimed at investigating the current situation of surgical treatments and prognosis for acute epidural hematoma in China, and analyzing the optimization of therapy.


Description:

The incidence of Acute Epidural Hematoma (AEDH) among traumatic brain injury (TBI) patients has been reported to be in the range of 2.7 to 4%. The mortality in patients in all age groups and GCS scores undergoing surgery for evacuation of EDH is approximately 10%. Most people with EDH are generally expected to have a good clinical outcome with the prompt and correct treatment. However, AEDH still represents a potentially life-threatening condition when a local mass effect exists due to rapidly elevated intracranial pressure (ICP) resulted from the rapid build-up of blood. Brain hernia and cerebral infarction might occur and lead to a terrible clinical outcome. In addition, there is a set of patients who experience clinical deterioration after an initial hematoma-evacuation craniotomy because of secondary brain injuries, including massive cerebral infarction (MCI), additional decompressive craniectomy is recommended as soon as possible. Although DC can reduce the morbidity and mortality in critically ill patients with a sTBI, the removal of the bone flap is not necessary for the majority of patients with AEDH, because of the relatively low incidence of MCI secondary to AEDH. Recommendations indicated an epidural hematoma greater than 30 ml should be surgically evacuated regardless of the patient's GCS score. Although craniotomy provides a complete evacuation to remove the clot of the hematoma, there are insufficient data to support a specific surgical treatment method. The choice of operative technique is influenced by the surgeon's expertise, training, and evaluation of a particular situation. Therefore, there is a clinical rationale for investigating the current status of surgical treatments and prognosis for AEDH, thereby providing a reliable reference for the optimization of therapy.


Recruitment information / eligibility

Status Recruiting
Enrollment 2000
Est. completion date December 31, 2023
Est. primary completion date June 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Clear medical history of traumatic brain injury; 2. within 12 hours after injury; 3. Supratentorial unilateral acute epidural hematoma on first head CT scan examination; 4. The admitting neurosurgeon considers that the epidural hematoma needs to be evacuated with surgical treatment; 5. With informed consent to surgery and trial participation. Exclusion Criteria: 1. Previous intracranial surgery prior to trauma; 2. Patients with a score of 3 on the GCS, with bilateral fixed and dilated pupils, bleeding diathesis or defective coagulation, or an injury that was deemed to be unsurvivable; 3. CT demonstrates associated other intracranial hematomas e.g. subdural, intracerebral hemorrhage, or large size infarction, which are the main causes of operation; 4. Patients who had injury of the oculomotor nerve; 5. Severe pre-existing disability or severe co-morbidity which would lead to a poor outcome even if the patient is supposed to a good recovery from the TBI; 6. Pregnant female.

Study Design


Locations

Country Name City State
China Department of Neurosurgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai Shanghai

Sponsors (3)

Lead Sponsor Collaborator
RenJi Hospital Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shenzhen Second People's Hospital

Country where clinical trial is conducted

China, 

References & Publications (4)

Bullock MR, Chesnut R, Ghajar J, Gordon D, Hartl R, Newell DW, Servadei F, Walters BC, Wilberger JE; Surgical Management of Traumatic Brain Injury Author Group. Surgical management of acute epidural hematomas. Neurosurgery. 2006 Mar;58(3 Suppl):S7-15; discussion Si-iv. Review. — View Citation

Li LM, Kolias AG, Guilfoyle MR, Timofeev I, Corteen EA, Pickard JD, Menon DK, Kirkpatrick PJ, Hutchinson PJ. Outcome following evacuation of acute subdural haematomas: a comparison of craniotomy with decompressive craniectomy. Acta Neurochir (Wien). 2012 Sep;154(9):1555-61. doi: 10.1007/s00701-012-1428-8. Epub 2012 Jun 30. — View Citation

Lin H, Wang WH, Hu LS, Li J, Luo F, Lin JM, Huang W, Zhang MS, Zhang Y, Hu K, Zheng JX. Novel Clinical Scale for Evaluating Pre-Operative Risk of Cerebral Herniation from Traumatic Epidural Hematoma. J Neurotrauma. 2016 Jun 1;33(11):1023-33. doi: 10.1089/neu.2014.3656. Epub 2016 Jan 28. — View Citation

Wang WH, Hu LS, Lin H, Li J, Luo F, Huang W, Lin JM, Cai GP, Liu CC. Risk factors for post-traumatic massive cerebral infarction secondary to space-occupying epidural hematoma. J Neurotrauma. 2014 Aug 15;31(16):1444-50. doi: 10.1089/neu.2013.3142. Epub 2014 Jun 25. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary GOSE (extended Glasgow Outcome Scale) scores The primary outcome is indicated by the long-term functional outcomes, including overall mortality and the score on the Extended Glasgow Outcome Scale (GOS-E), "Extended Glasgow Outcome Scale" is the unabbreviated scale title. The minimum value of scale is score 1, and maximum value is scored 8, higher scores mean a better outcome and lower scores mean worse outcome. Specific scored as follows:
death;
persistent vegetative state;
lower severe disability;
upper severe disability; (stratum 3 and 4 were considered as severe disability, with permanent requirement for help with daily living);
lower moderate disability;
upper moderate disability; (stratum 5 and 6 were considered as mild disability, without a need for assistance in everyday life, that might, however, require special equipment for employment);
lower good recovery;
upper good recovery (stratum 7 and 8 were considered as good recovery).
at 6 months post-injury
Secondary incidence of post-operative cerebral infarction The incidence of traumatic AEDH post-operative cerebral infarction within 6 months post-injury, which is primarily diagnosed by independent radiologists with CT or MRI examination. within 6 months post-injury
Secondary incidence of additional craniocerebral surgery The incidence of additional craniocerebral surgery within 6 months post-injury, related to clinical deterioration after initial surgical treatment of AEDH. within 6 months post-injury
Secondary length of stay in ICU and hospital The duration of hospitalization after initial surgery within 6 months post-injury, including ICU and hospital stays. within 6 months post-injury
Secondary detailed economic evaluation Total medical expense related to treatment of AEDH, including the costs of operations, hospitalization and rehabilitation within 6 months post-injury. within 6 months post-injury
Secondary incidence of serious adverse events Serious adverse events (SAE) is defined as an untoward occurrence that:
results in death
is life-threatening
requires hospitalisation or prolongation of existing hospitalization
results in persistent or significant disability or incapacity
is otherwise considered medically significant by the investigator.
within 6 months post-injury
Secondary quality of life (EQ-5D-5L) Unabbreviated scale title is "5-level EuroQol five dimensions" questionnaire. The EQ-5D is a generic instrument for describing and valuing health. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. at 6 months post-injury
Secondary MMSE (mini-mental state examination) scores MMSE (mini-mental state examination) scores at 6 months post-injury. at 6 months post-injury
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02880566 - Efficacy of Scalp Block on Hemodynamic Stability and Opioid Consumption During Craniotomy N/A
Completed NCT05103735 - Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity
Completed NCT04285359 - Impact of Severe Intraoperative Hyperglycemia on Infection Rate After Elective Intracranial Interventions
Completed NCT03364283 - Sitting Versus Horizontal Position on Craniotomies
Completed NCT01502540 - Pain Prevalence After Major Craniotomy N/A
Recruiting NCT06157359 - Effect of SNB on the QoR in Patients Undergoing Supratentorial Tumor Resection N/A
Recruiting NCT01474304 - Intravenous Acetaminophen for Craniotomy Patients Phase 2
Completed NCT01617837 - The Efficacy of P6 Acupressure in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy Phase 2/Phase 3
Completed NCT01987648 - eCRANIO Trial Study on Elective CRAniotomies: Postoperative Neurointensive Care, Imaging and Outcome
Recruiting NCT05962684 - A Greek-designed ERAS Protocol in Elective Craniotomy
Recruiting NCT04261673 - Prospective Randomized Evaluation of Decompressive Ipsilateral Craniectomy for Traumatic Acute Epidural Hematoma N/A
Completed NCT05940935 - The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations
Completed NCT03033706 - Intraoperative Goal Directed Fluid Management in Supratentorial Brain Tumor Craniotomy N/A
Completed NCT00658242 - Craniofacial Surgery Perioperative Registry N/A
Completed NCT04859907 - Bone Flap Fixation Systems For Craniotomy Procedures N/A
Active, not recruiting NCT02237716 - Rapid Intravenous Infusion of Mannitol Results in a Dipper-type Change in Stroke Volume Variation in Patients Undergoing Major Neurosurgery N/A
Recruiting NCT01966939 - Influences of Types of Skull Surgery on Temporomandibular Joint Performance N/A
Completed NCT01606969 - Comparison of Epinephrine-lidocaine Solution and Dexmedetomidine -Lidocaine Solution N/A
Completed NCT00590499 - Agitation in Post Operative Neurosurgical Patients N/A
Withdrawn NCT01282645 - Case Series to Evaluate Patient Specific Implants (PSI) in Polyether Ether Ketone (PEEK) Performance After 2 Years N/A